Skip to content

AstroNova, Inc. ALOT Guaranteed Minimum Royalty Payments

Guaranteed Minimum Royalty Payments at other companies

Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$525K0.0%
U.S. Gold Corp. logo
U.S. Gold Corp.USAU
$125K-16.7%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$32.8M+5.9%
AMP
Amphastar PharmaceuticalsAMPH
$7.5M
Evolus logo
EvolusEOLS
$1.89M-20.0%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$121.63M+0.1%

Other financials

Income statement

See full
Revenue$39.4M+4.4%
Gross profit$14.4M+20.7%
Operating income$1.6M+174%
Net income$653.0K+274%
EPS (diluted)$0.08+260%

Balance sheet

See full
Cash & equivalents$4.7M-12.7%
Total debt$22.9M-1.3%
Total equity$77.5M+1.3%
Total assets$139.9M-7.0%

Cash flow

See full
Operating cash flow$3.0M-31.3%
CapEx$36.0K-40.0%
Free cash flow$3.0M-31.1%

Valuation

See full
Market cap$221.25M+214%
Enterprise value$239.45M+171%
P/S1.5×+1.0×

Profitability

See full
Gross margin32.5%0.0pp
Operating margin1.4%+0.8pp
Net margin-0.9%-0.4pp
FCF margin6.6%

Returns & leverage

See full
Return on equity-1.7%-0.8pp
Debt / equity0.3×0.0×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by AstroNova, Inc. in its filing.

Tagged under the XBRL concept alot:GuaranteedMinimumRoyaltyPayments.

The official record: AstroNova, Inc.’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AstroNova, Inc.'s guaranteed minimum royalty payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AstroNova, Inc.'s guaranteed minimum royalty payments?
AstroNova, Inc. (ALOT) reported guaranteed minimum royalty payments of $300K in Q1 2026.
How has AstroNova, Inc.'s guaranteed minimum royalty payments changed year-over-year?
AstroNova, Inc.'s guaranteed minimum royalty payments decreased by 97.7% year-over-year, from $13.3M to $300K.
What does guaranteed minimum royalty payments mean?
Represents the fixed, non-contingent contractual obligations to pay for the use of intellectual property or licensed technology regardless of actual sales volume. This metric serves as a measure of fixed operational risk and long-term commitment to third-party technology partners.